ACE and atherosclerosis: Despite several current standard therapies for atherosclerosis that may influence general immune responses, including angiotensin-converting enzyme (ACE) inhibitors, β-blockers, aspirin, and corticosteroids, these drugs lack specific macrophage targeting and may only be recognized as mild modifiers of macrophage activity [218].